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Abstract
Objectives The ultrasonic NO PAIN technology (Electro
Medical Systems, Nyon, CH) promises minimal pain during
debridement due to linear oscillating action combined with a
sinusoidal power output and feedback control. The aim of the
present study was to measure pain perception on a visual
analogue scale (VAS) during supportive periodontal therapy
including debridement of hypersensitive teeth. Two ultrasonic
scalers were used, one with and one without NO PAIN
technology.
Material and methods In a randomized-controlled clinical
study with split-mouth design, 100 hypersensitive teeth
matched for air blast hypersensitivity were either treated with
the ultrasonic device Piezon Master 700 or the Mini Piezon
(both EMS, Nyon, CH). Pain perception during debridement
was assessed by a VAS (range 0–10).
Results The average VAS for the test device Piezon Master
700 with NO PAIN technology was 3.16 ± 2.10, and for the
control device Mini Piezon without NO PAIN technology
3.40 ± 2.59 (p = 0.490). Placing an arbitrary threshold at the
VAS score of 3 for significant pain experience, 60 % of the
subjects experienced no significant pain with either
instrument.
Conclusion No statistically significant difference in perceived
pain between the instruments used was found.
Clinical relevance Both ultrasonic devices showed very small
pain intensities during debridement of highly hypersensitive
teeth and can therefore be recommended for supportive peri-
odontal therapy.
Keywords Debridement . Pain . Ultrasonic scaler .
Supportive periodontal therapy . Non-surgical periodontal
therapy . Visual analogue scale
Background
The Consensus report of the 11th European Workshop on
Periodontology on effective prevention of periodontal and
peri-implant diseases reinforced the need to enrol patients
treated for periodontitis in a supportive periodontal therapy
regimen [1]. Supportive periodontal therapy aims at
preventing the recurrence of periodontal disease in terms of
tooth loss and additional attachment loss through periodic
preventive interventions [2, 3]. Such regimen includes routine
assessments of disease and oral hygiene status, behaviour
modification and professional mechanical plaque and calculus
removal (PMPR) [2]. The importance and effectiveness of
supportive periodontal therapy in the secondary prevention
of periodontal disease have been well established [1]. The
authors of the Consensus report of the 11th European
Workshop on Periodontology concluded that patients treated
for periodontitis can maintain their dentition with limited var-
iations in periodontal parameters when regularly complying
with a supportive periodontal therapy regimen based on rou-
tine PMPR [1]. Additionally, patients irregularly complying
with the planned supportive periodontal therapy regimen
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showed greater tooth loss and disease progression when com-
pared to patients who comply regularly [1, 4].
Pain during PMPRwas recently reported to be a significant
factor influencing clinical compliance to periodontal therapy
[5]. The healing of periodontal tissues after active periodontal
therapy often results in gingival recession, and in addition,
root debridement leads to loss of cementum [6, 7]. The short,
sharp pain arising from exposed dentin in response to thermal,
tactile, osmotic or chemical stimuli has been defined as dentin
hypersensitivity [8]. Levels of dentin hypersensitivity may
increase after surgical as well as non-surgical periodontal
treatment [9–11]. Among periodontal patients, the occurrence
of root sensitivity has been reported to reach up to 98 % [12].
PMPR often induces dentin hypersensitivity due to thermal or
tactile stimuli. The ability to deliver dental care with a mini-
mum of patient discomfort should be an essential part of a
clinician’s skills to avoid a decline of compliance with sup-
portive periodontal therapy [13].
The EMS Piezon® NO PAIN technology (Electro
Medical Systems (EMS), Nyon, CH) promises minimal
pain during PMPR and no injury of the gingiva, due to
controlled linear oscillating instrument movements parallel
to the tooth surface, combined with a sinusoidal power
output and feedback control [14].
The aim of the present randomized-controlled clinical
study was to compare subjective pain intensities during
PMPR of hypersensitive teeth with two piezoelectric ultrason-
ic devices, one including NO PAIN technology (Piezon
Master 700, EMS, Nyon, CH), and one without (Mini
Piezon, EMS, Nyon, CH).
Material and methods
Ethical considerations
The Ethics Committee of the Medical University of
Innsbruck, Austria, approved the study. The study was con-
ducted in accordance with the 1964 Helsinki declaration and
its later amendments. All subjects signed an informed written
consent prior to the study enrolment.
Study subjects
For the study, 53 patients of the dental clinic of the Medical
University of Innsbruck who were known for generalized and
severe dentin hypersensitivity were recruited (Fig. 1). Subjects
had to exhibit a minimum of two hypersensitive teeth in two
different quadrants. For the respective teeth, an air blast stim-
uli score of 2 or 3 (Schiff Cold Air Sensitivity Scale - SCASS)
had to be present at the baseline examination. Both teeth of the
subject had to feature the same air blast stimuli score.
Additionally, test and control teeth had to be from the same
tooth category (category 1: incisive, category 2: canines and
premolars, category 3: molars). Any teeth with cracked enam-
el, enamel defects, caries, or extensive/defective restorations,
clinically diagnosed pulpitis, and teeth with orthodontic appli-
ances were excluded. Additional exclusion criteria
encompassed subjects with gross oral pathology, PMPR or
orthodontic treatment within the last 3 months, subjects with
eating disorders, as well as pregnant or lactating women, and
psychiatric disorders. Current users of anticonvulsants, anti-
histamines, antidepressants, sedatives, tranquillisers, anti-
inflammatory drugs or daily analgesics were also excluded.
Clinical intervention
At baseline, one investigator (HH) measured tactile and
air blast hypersensitivity and selected two hypersensitive
teeth in two different quadrants with SCASS 2 or 3. For
SCASS, the test and control teeth were isolated from the
adjacent teeth by the placement of red boxing wax. Air
was delivered from a standard dental unit air syringe at
maximal pressure (45 psi) and at an environmental tem-
perature of 19–24°. Air was applied for 1 s at a distance
of 1 cm perpendicular to the buccal surface of the tooth.
The SCASS was used to assess the subject’s response to
the stimulus. The scale is graduated into four units:
0 = subject does not respond to the stimulus; 1 = subject
does not respond to the stimulus, but considers stimulus
to be painful; 2 = subject responds to air stimulus, but
does not move away from the stimulus; 3 = subject re-
sponds significantly to air stimulus, moves away from the
stimulus, and requests immediate termination of the stim-
ulus [15]. Patients were informed before testing about the
Fig. 1 Patient flow chart. Patients were preselected by their dentist/
student regarding inclusion and exclusion criteria. Only patients known
for generalized and severe dentin hypersensitivity were recruited for the
clinical trial
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different units of the scale. Tactile hypersensitivity was
assessed by scratching on the dentinal surface with a
sharp-tipped probe and a maximum pressure of 70 g.
Pressure of 70 g was calibrated with a letter balance be-
fore each investigation. The subjects graded pain intensity
on a visual analogue scale (VAS) (0 = no pain and 10 = ex-
treme, unbearable pain). Patients were instructed to point
at the VAS. Probing pocket depths recorded at six sites
per tooth were available from all patients. Recession
depth was measured on the buccal aspect of the tooth.
Both teeth were matched for air blast hypersensitivity and
were randomly assigned by the second investigator (MS) to
one of two treatment groups by rolling a dice: (1)
supragingival debridement for 30 s using an ultrasonic scaler
with the specific NO PAIN technology (Piezon Master 700,
EMS, Nyon, CH), or (2) supragingival debridement for 30 s
using an ultrasonic scaler without the NO PAIN technology
(Mini Piezon, EMS, Nyon, CH). For both devices, the same
tip was used (EMS Instrument PS). According to oral advice
of the manufacturer, the power of both devices was set to
50 %. Temperature of physiological saline solution and
water for cooling was adjusted to 24 °C. During
debridement, the lower end of the tip was applied from
coronal to apical with minimal pressure using brushing
strokes parallel to the tooth surface. The blinded investigator
HH performed the follow-up examinations: Intervention
blinded patients were asked to protocol their perception of
the instrumentation immediately after the treatment (main out-
come measure) on an interval scale (VAS) ranging from 0,
representing no pain or discomfort, to 10, representing maxi-
mum pain and discomfort.
Statistical analyses
Standard descriptive methods were used to summarize the
parameters studied. The Wilcoxon signed-rank test was used
to evaluate differences between values for pain perception
during PMPR (VAS, main outcome). Differences of baseline
hypersensitivity levels between treatment groups were evalu-
ated with the chi-square test (SCASS) or Wilcoxon signed-
rank test (tactile hypersensitivity, VAS). All statistical tests of
the hypotheses were two-sided, and a level of significance of
alpha = 0.05 was employed.
Results
Baseline data
One hundred teeth in 50 subjects (31 females, 19 males) were
enrolled in the study. All participants were Caucasians, aged
20–79 years (mean age ± SD = 44.84 ± 14.06). Fifty-six per-
cent of the subjects had never smoked before, and 44 % were
smokers. Thirty-six subjects showed baseline SCASS 2 on
matched test and control teeth, and 14 subjects exhibited with
SCASS 3 on matched test and control teeth. Six subjects with
tooth category 1, 27 subjects with tooth category 2, and 17
subjects with tooth category 3 were included. There was no
statistical significant difference between test and control teeth
in baseline tactile hypersensitivity (VAS baseline 1.60 ± 2.09
and 1.62 ± 2.19, respectively; p = 0.617) (Table 1).
No statistically significant difference in perceived pain
between the instruments used was found. For the test
device Piezon Master 700 with NO PAIN technology,
the average VAS value during debridement was
3.16 ± 2.10, and for the control device Mini Piezon
without NO PAIN technology, this was 3.40 ± 2.59
(p = 0.490). The median was 3 for both instruments
(range 1–10) (Fig. 1). Placing an arbitrary threshold for
significant pain experience at the VAS score of 3 [16],
60 % (n = 30) of the subjects experienced no significant
pain (VAS 0 to 3) with either instrument. Further assum-
ing another arbitrary limit at 7 [16], two subjects per-
ceived great pain (VAS 7 to 10) during treatment with
the Piezon Master 700, and seven patients perceived
great pain during treatment with the Mini Piezon
(Fig. 2).
Table 1 Dentin hypersensitivity at baseline and pain perception during







Category 1: incisives, n 6 6
Category 2: canines and premolars, n 27 27
Category 3: molars, n 17 17
Periodontal parameters
Probing pocket depth, m ± sd 3.43 ± 1.44 3.40 ± 1.47
Recession depth, m ± sd 2.03 ± 1.27 2.30 ± 1.26
Airblast sensitivity scale
SCASS 2, n 36 36
SCASS 3, n 14 14
Tactile sensitivity scale, baseline
Visual analogue scale, m ± sd 1.60 ± 2.09 1.62 ± 2.19
Pain perception during debridement
Visual analogue scale, m ± sd 3.16 ± 2.10 3.40 ± 2.59
One hundred teeth in 50 subjects (31 females, 19 males; mean
age ± SD = 44.84 ± 14.06) were enrolled in the study. Fifty-six percent
of the subjects had never smoked before, and 44 % were smokers. Two
teeth in two different quadrants were matched for SCASS and tooth
category




Many studies have highlighted the importance of regular sup-
portive periodontal therapy including PMPR. Among the
most well-known studies are Hirschfield and Wasserman
[17], McFall [18], Lindhe and Nyman [19], Goldman et al.
[20], and Axelsson and Lindhe [21]. Indeed, there is a signif-
icant increase in tooth loss in non-compliers or irregular com-
pliers compared to compliers [22]. Incidence of new sites with
probing depth of > or =5 mm varied between 3.2 % for the
compliant and 5.8 % for the non-compliant patients (mean
delay from the scheduled recall sessions: compliant within
1–6 weeks; and not compliant >6 weeks) [23]. A painless
treatment increases patient comfort during PMPR, and might
therefore increase patient compliance [5]. This in turn may
provide a better long-term prognosis for periodontal therapy.
In the present randomized-controlled and double blind trial,
100 teeth with dentin hypersensitivity were enrolled. Two
teeth in each subject were matched according to air blast hy-
persensitivity and tooth category and were randomly assigned
to debridement with an ultrasonic device with or without NO
PAIN technology. Debridement of hypersensitive dentin was
restricted on supragingival areas to avoid pain by gingival
injury, which would have falsified the result. Pain perception
of the instrumentation was recorded instantly with a VAS.
Verbal reports are known to be shaped by a variety of psycho-
social variables. Additionally, pain is not a simple sensory
state but is influenced by cultural learning, the meaning of
the situation, attention and other psychological variables
[24]. Therefore, to overcome inter-individual differences be-
tween test and control patients, we investigated both devices
in a split-mouth clinical trial. To overcome intra-individual
differences in pain perception between different teeth, tooth
categories and air blast hypersensitivity were matched be-
tween test and control teeth.
Pain perception during instrumentation was low for both
ultrasonic devices (VAS median 3), and there was no statis-
tically significant difference between the two treatment mo-
dalities. More subjects (n = 7) perceived great pain (VAS 7–
10) with the Mini Piezon compared to subjects exposed to
the Piezon Master 700 (n = 2) (Fisher Exact Probability
Test: p = 0.159). Our results are in line with previous studies
on pain perception during debridement with piezoceramic
ultrasonic devices. Braun et al. compared pain intensities
during debridement with hand instruments (Gracey-curettes,
Hu-Friedy, Leimen, Germany), a piezo ultrasonic instrument
(SirosonTMS, instrument N°3, Siemens, Bensheim,
Germany) or the Vector™-system (Duerr Dental,
Bietigheim-Bissingen, Germany); mean VAS values for pain
perception during therapy was 3.7 ± 1.8 for the piezo ultra-
sonic device [25]. Kocher et al. compared pain intensities
during debridement with a sonic (Sonicflex2000, KaVo,
Biberach, Germany) and a piezoceramic ultrasonic scaler
(PiezonMaster 400, EMS, Nyon, CH) in a split-mouth
Fig. 2 Box plot for the pain perception during debridement (median,
outliers, 10, 25, 75, and 90 % percentiles). Pain perception of the
instrumentation was assessed immediately after the treatment on an
interval scale (visual analogue scale, VAS) ranging from 0, representing
no pain or discomfort, to 10, representing maximum pain and discomfort.
With a median of 3, pain perception was low for both devices
Fig. 3 Frequency distribution of VAS scores for the treatment with a the
Piezon Master 700 and b the Mini Piezon (both EMS, Nyon, CH). Pain
perception of the instrumentation was assessed immediately after the
treatment on an interval scale (visual analogue scale, VAS) ranging from
0, representing no pain or discomfort, to 10, representing maximum pain
and discomfort. Placing an arbitrary threshold at the VAS score of 3, 60%
(n = 30) of the subjects experienced no significant pain with either
instrument. Further assuming another arbitrary limit at 7, two subjects
perceived great pain during treatment with the Piezon Master 700, and
seven patients perceived great pain during treatment with the Mini Piezon
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design; the median VAS was 3 for both instruments [16].
Kocher et al. concluded that the motion of the instrument’s
tip might be redundant with respect to perceived pain [16].
The EMS Piezon® NO PAIN technology (Electro Medical
Systems (EMS), Nyon, CH) promises minimal pain during
PMPR and no injury of the gingiva, due to controlled linear
oscillating instrument movements parallel to the tooth sur-
face, combined with a sinusoidal power output and feedback
control [14]. Emmelmann studied in his thesis the mo-
tion of instrument tips in an unloaded and loaded mode
with a high speed camera with 7500 frames-per-second
and provided first evidence that the instrument’s tip
(EMS® Instrument P) of the Piezon Master 700 has a
slight elliptic motion [26]. Possibly, the motion of the
instrument’s tip with the Piezon Master 700 is very
similar to the Mini Piezon, which is also equipped with
the Piezon® technology (Fig. 3). The feedback control
does not seem to have a significant effect on pain re-
duction in supportive periodontal therapy where little calculus
is present.
In conclusion, both ultrasonic devices investigated in the
present study showed very small pain intensities during de-
bridement of highly hypersensitive teeth and can therefore be
recommended for supportive periodontal therapy.
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